JUNIPER PHARMACEUTICALS INC Finite-Lived Intangible Asset, Expected Amortization, Year Five
JUNIPER PHARMACEUTICALS INC had Finite-Lived Intangible Asset, Expected Amortization, Year Five of $185.00 thousand as of 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Notes › Intangible Assets › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive · last filed 2016-11-14
- 2016-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year Five $185.00K.
- 2016-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year Five $191.00K.
- 2016-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $205.00K.
- 2015-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $212.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Five |
|---|---|
| 2016-09-30 | $185.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $191.00K 10-Q/A · filed 2016-11-14 |
| 2016-03-31 | $205.00K 10-Q · filed 2016-11-14 |
| 2015-12-31 | $212.00K 10-K/A · filed 2016-11-14 |
| 2015-09-30 | $294.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $305.00K 10-Q · filed 2015-08-04 |
| 2015-03-31 | $288.00K 10-Q · filed 2015-05-06 |
| 2014-09-30 | $348.00K 10-Q · filed 2014-10-31 |
| 2014-06-30 | $365.00K 10-Q · filed 2014-08-01 |
| 2014-03-31 | $357.00K 10-Q · filed 2014-05-02 |